Boron neutron capture therapy for malignant gliomas [Review].
Methods for boron analysis in boron neutron capture therapy (BNCT) [Review].
Monitoring of blood-1013 concentration for boron neutron capture therapy using prompt [gamma]-ray analysis.
Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies.
Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Monday that it has entered into an agreement with Neutron Therapeutics Inc, a US based medical equipment company that is developing a comprehensive solution for
boron neutron capture therapy (BNCT), regarding treatment planning for BNCT, which is a unique type of radiation therapy that enables targeting of cancer at the cellular level.
The technology was showcased today at the IAEAs General Conference side event called Recent Advances in Boron Neutron Capture Therapy Using Research Reactors and Accelerators.
Recent advances have ushered Boron Neutron Capture Therapy into a new phase of optimism with high success rates in different types of cancers, said Joao Osso, Head of the IAEA Radioisotope Products and Radiation Technology Section.
Recent advances in research and clinical applications of Boron Neutron Capture Therapy have prompted the IAEA to provide increased support in the field.
